Research Analysts Issue Forecasts for UAMY FY2025 Earnings

United States Antimony Co. (NYSE:UAMY) – Equities research analysts at HC Wainwright raised their FY2025 EPS estimates for United States Antimony in a report issued on Tuesday, July 1st. HC Wainwright analyst H. Ihle now expects that the company will earn $0.06 per share for the year, up from their prior forecast of $0.04. HC Wainwright has a “Buy” rating and a $4.50 price target on the stock. The consensus estimate for United States Antimony’s current full-year earnings is ($0.01) per share.

A number of other research analysts also recently weighed in on UAMY. Wall Street Zen downgraded shares of United States Antimony from a “hold” rating to a “sell” rating in a research report on Thursday, May 15th. D. Boral Capital reiterated a “buy” rating and set a $5.00 target price on shares of United States Antimony in a research report on Monday, May 12th. D Boral Capital raised shares of United States Antimony to a “strong-buy” rating in a report on Wednesday, April 23rd. Finally, B. Riley restated a “buy” rating on shares of United States Antimony in a research report on Tuesday, April 15th. One analyst has rated the stock with a sell rating, four have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $3.38.

United States Antimony Stock Up 4.0%

Shares of UAMY stock opened at $2.22 on Wednesday. The company has a debt-to-equity ratio of 0.01, a quick ratio of 5.84 and a current ratio of 6.24. United States Antimony has a fifty-two week low of $0.27 and a fifty-two week high of $3.86. The firm has a market capitalization of $263.81 million and a PE ratio of -55.38. The stock’s 50-day simple moving average is $2.81 and its 200-day simple moving average is $2.25.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of UAMY. Tower Research Capital LLC TRC lifted its stake in United States Antimony by 2,205.1% in the fourth quarter. Tower Research Capital LLC TRC now owns 26,716 shares of the company’s stock worth $47,000 after acquiring an additional 25,557 shares during the last quarter. Cetera Investment Advisers acquired a new position in United States Antimony in the fourth quarter valued at approximately $40,000. Two Sigma Advisers LP acquired a new position in United States Antimony in the fourth quarter valued at approximately $407,000. Geode Capital Management LLC lifted its position in shares of United States Antimony by 2.2% during the 4th quarter. Geode Capital Management LLC now owns 788,728 shares of the company’s stock worth $1,397,000 after buying an additional 16,905 shares during the last quarter. Finally, Two Sigma Investments LP purchased a new position in shares of United States Antimony in the 4th quarter valued at $565,000. 9.49% of the stock is owned by institutional investors and hedge funds.

United States Antimony Company Profile

United States Antimony Corporation produces and sells antimony, silver, gold, precious metals, and zeolite products in the United States, and Canada. It operates through Antimony, Zeolite, and Precious Metals segments. The company offers antimony oxide that is primarily used in conjunction with a halogen to form a synergistic flame retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper, as well as color fastener in paints and as a phosphorescent agent in fluorescent light bulbs; antimony trisulfide used as a primer in ammunition; and antimony metal for use in bearings, storage batteries, and ordnance.